Renaissance Technologies’s Bluejay Diagnostics BJDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BJDX
SM
Renaissance Technologies's BJDX Position: Q1 2026 in Review
Renaissance Technologies sold out of Bluejay Diagnostics (BJDX) in Q1 2026, closing a stake of 2,006 shares — an estimated $21.4K sold.
Renaissance Technologies first reported a position in BJDX in Q4 2022 and held it in 4 quarters. The position peaked at $25K in Q4 2022. 6 funds tracked by Wall St. Rank hold BJDX as of Q1 2026.
- Renaissance Technologies reported no remaining Bluejay Diagnostics position as of Q1 2026 after selling out during the quarter.
- Renaissance Technologies sold 2,006 Bluejay Diagnostics shares in Q1 2026, an estimated $21.4K.
- Renaissance Technologies first reported a position in Bluejay Diagnostics in Q4 2022 and held it in 4 quarters.
- Renaissance Technologies's Bluejay Diagnostics position peaked at $25K in Q4 2022.
- 6 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.